12/19
12:45 pm
rnac
Rating for RNAC
Low
Report
Rating for RNAC
12/19
09:09 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is now covered by analysts at BTIG Research. They set a "buy" rating and a $42.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is now covered by analysts at BTIG Research. They set a "buy" rating and a $42.00 price target on the stock.
12/19
06:46 am
rnac
Cartesian Therapeutics initiated with a Buy at BTIG
High
Report
Cartesian Therapeutics initiated with a Buy at BTIG
12/4
08:09 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock, up previously from $41.00.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock, up previously from $41.00.
12/3
09:03 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
12/3
08:02 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.
Low
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.
12/3
04:54 am
rnac
Rating for RNAC
Low
Report
Rating for RNAC
12/3
04:54 am
rnac
Rating for RNAC
Low
Report
Rating for RNAC
11/25
08:05 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
11/25
07:12 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
11/25
07:12 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
11/8
08:46 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Low
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
11/8
04:50 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
11/8
04:50 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
10/16
08:31 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
10/16
06:44 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC
10/16
06:44 am
rnac
Rating for RNAC
Medium
Report
Rating for RNAC